CY2286B1 - Method for preventing zoster or alleviating varicella related post-herpetic neuralgia - Google Patents

Method for preventing zoster or alleviating varicella related post-herpetic neuralgia

Info

Publication number
CY2286B1
CY2286B1 CY0200040A CY0200040A CY2286B1 CY 2286 B1 CY2286 B1 CY 2286B1 CY 0200040 A CY0200040 A CY 0200040A CY 0200040 A CY0200040 A CY 0200040A CY 2286 B1 CY2286 B1 CY 2286B1
Authority
CY
Cyprus
Prior art keywords
varicella
alleviating
herpetic neuralgia
related post
zoster
Prior art date
Application number
CY0200040A
Other languages
English (en)
Inventor
Gary B Calandra
Philip J Provost
Myron J Levin
C Jo White
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25435290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2286(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CY2286B1 publication Critical patent/CY2286B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Exchange Systems With Centralized Control (AREA)
CY0200040A 1992-07-17 2002-06-19 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia CY2286B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91514192A 1992-07-17 1992-07-17

Publications (1)

Publication Number Publication Date
CY2286B1 true CY2286B1 (en) 2003-07-04

Family

ID=25435290

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200040A CY2286B1 (en) 1992-07-17 2002-06-19 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia

Country Status (15)

Country Link
US (2) US5997880A (de)
EP (1) EP0651789B2 (de)
JP (3) JP4562812B2 (de)
AT (1) ATE210722T1 (de)
AU (1) AU687355B2 (de)
CA (1) CA2139515C (de)
CY (1) CY2286B1 (de)
DE (2) DE69331322T3 (de)
DK (1) DK0651789T4 (de)
ES (1) ES2165367T5 (de)
LU (1) LU91287I2 (de)
LV (1) LV12832B (de)
NL (1) NL300246I2 (de)
PT (1) PT651789E (de)
WO (1) WO1994002596A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
BRPI0906527A2 (pt) * 2008-04-04 2016-09-06 3Mm Innovative Properties Company aparelho para aplicação de bandagens em ferimentos e bandagem médica
UA112970C2 (uk) * 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
WO2014043189A1 (en) 2012-09-14 2014-03-20 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes viruses and use thereof in vaccines
WO2015034807A2 (en) 2013-09-05 2015-03-12 Merck Sharp & Dohme Corp. Methods of immunization with varicella zoster virus antigen
CN108778289B (zh) 2015-11-06 2020-11-17 佐剂技术公司 三萜皂苷类似物
CA3061205A1 (en) 2017-04-25 2018-11-01 Memorial Sloan Kettering Cancer Center Triterpene saponin analogues
BR112022017852A2 (pt) 2020-03-09 2022-11-01 Dynavax Tech Corp Vacinas para herpes zoster compreendendo um agonista de tlr9
JP7442386B2 (ja) 2020-05-14 2024-03-04 東京エレクトロン株式会社 基板処理装置

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US376788A (en) * 1888-01-24 strait
US441737A (en) * 1890-12-02 Tapping-machine for stay-bolt holes
JPS5341202B2 (de) * 1974-03-12 1978-11-01
US4000256A (en) * 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
US4008317A (en) * 1975-12-29 1977-02-15 Recherche Et Industrie Therapeutiques (R.I.T.) Varicella-zoster virus vaccine and preparation thereof
US4147772A (en) * 1976-02-03 1979-04-03 Merck & Co., Inc. Vaccine stabilizer
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
EP0101200A3 (de) * 1982-07-20 1985-03-06 BIO-COM Inc. Transferfaktor zur Anwendung in der Behandlung von Virusinfektionen
US4769239A (en) * 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
EP0211756A1 (de) * 1985-08-01 1987-02-25 Merck & Co. Inc. Assay für Varicella-Zoster-Virus (VZV)-Antikörper
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
NZ220645A (en) * 1986-06-20 1989-10-27 Merck & Co Inc Modified varicella-zoster virus and its cultivation
US5024836A (en) * 1987-05-04 1991-06-18 Merck & Co., Inc. Stable lyophilized live herpes virus vaccine
DE69017769T2 (de) * 1989-06-27 1995-07-13 Smithkline Beecham Biologicals S.A., Rixensart Verbindungen.
ES2150906T3 (es) * 1990-10-04 2000-12-16 Res Corp Technologies Inc Antigeno del virus varicella-zoster.

Also Published As

Publication number Publication date
NL300246I2 (nl) 2007-02-01
DE122006000063I1 (de) 2007-05-10
LV12832B (lv) 2002-09-20
JP2010189420A (ja) 2010-09-02
EP0651789A4 (de) 1996-06-26
DE69331322T3 (de) 2009-10-22
ES2165367T3 (es) 2002-03-16
AU687355B2 (en) 1998-02-26
CA2139515C (en) 2008-12-23
WO1994002596A1 (en) 1994-02-03
US6214354B1 (en) 2001-04-10
LV12832A (en) 2002-05-20
CA2139515A1 (en) 1994-02-03
ATE210722T1 (de) 2001-12-15
JPH07509244A (ja) 1995-10-12
EP0651789B1 (de) 2001-12-12
DK0651789T4 (da) 2009-07-27
JP4562812B2 (ja) 2010-10-13
PT651789E (pt) 2002-05-31
DK0651789T3 (da) 2002-03-11
LU91287I2 (fr) 2007-01-15
JP2004323531A (ja) 2004-11-18
AU4676093A (en) 1994-02-14
DE69331322T2 (de) 2002-08-08
DE69331322D1 (de) 2002-01-24
US5997880A (en) 1999-12-07
EP0651789A1 (de) 1995-05-10
EP0651789B2 (de) 2009-05-20
NL300246I1 (nl) 2007-01-02
ES2165367T5 (es) 2009-08-05

Similar Documents

Publication Publication Date Title
CY2286B1 (en) Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
WO1994003759A3 (en) Toroidal reflectors for optical system
FI945697L (fi) Menetelmä heikennetyn varicella Zoster -virusrokotteen valmistamiseksi
ATE55179T1 (de) Verfahren zur regelung von verbrennungsprozessen.
NO153692C (no) Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2).
IL69374A0 (en) Process for the preparation of a herpes antigen,an agent suitable for this and a process for its preparation,and the use of this antigen
AU5994596A (en) Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising fro m exposure to an antigen
JPS5439980A (en) Lighting tool for car
AU7655591A (en) Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus
WO2002088327A1 (en) Methods for viral oncoapoptosis in cancer therapy
JPS5445985A (en) Lighting apparatus for vehicles
HOORNAERT On the Conflicting Interpretations of “Sunyata” by the Madhyamika and the Yogacara
JPS57144503A (en) Adjuster for distribution of light volume
JPS5726877A (en) Copying machine
JPS5414746A (en) Illuninating light source device
CA2183721A1 (en) Electromagnetic Shutter and Cover
Tinsley Middle- and low-latitude emissions from energetic neutral ion precipitation seen from ATLAS 1 under quiet magnetic conditions
JPS53133449A (en) Lighting device for original of electrophotographic copier
JPS5417027A (en) Image forming system
Yuan A study of task light systems: hid kiosks and furniture mounted fluorescent lighting system
ZHENG et al. Study on the Correlation between Anti-Varicella—zoster Virus Antibody Titers and Severity of Pain in Patients with Herpes
Ulrich The nature of the broad line region: Optical/UV/X‐ray studies
JPS5437389A (en) Discharge lamp
ES8202419A1 (es) Metodo de iluminacion mediante fuentes luminosas intensas de pequeno tamano
JPS5386110A (en) Light volume adjusting mechanism of facsimile device